Biolex Therapeutics raised $154M from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, L.L.C., Dogwood Equity, Investor Growth Capital, Mitsui Ventures, Investor Growth Capital, JP Morgan, Easton Capital, Quaker BioVentures, Polaris Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development, Dow Venture Capital, Polaris Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, Kitty Hawk Capital, and Johnson & Johnson Development Corporation in 5 rounds.

Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug    fis.dowjones.com Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C    mitsuiventures.com BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS    biolex.com BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING    biolex.com

Accera raised $130.6M from POSCO BioVentures, Inventages Venture Capital Investment Inc., and POSCO BioVentures in 6 rounds.

SEC    sec.gov Accera, Inc.: Series D $11M    onbiovc.com Accera raises $35M    fiercebiotech.com SEC D/A    sec.gov SEC D/A    sec.gov SEC D    sec.gov

EBR Systems raised $56M from SV Life Sciences, Split Rock Partners, Frazier Healthcare Ventures, Delphi Ventures, De Novo Ventures, Frazier Healthcare Ventures, St. Paul Venture Capital, De Novo Ventures, and Split Rock Partners in 2 rounds.

GenVault raised $31M from QuestMark Partners, Montagu Newhall Associates, Domain Associates, Cross Creek Capital, QuestMark Partners, and Domain Associates in 2 rounds.

GenVault Corporation Raises $18 Million of Financing    genvault.com

CAPNIA raised $12M from Vivo Ventures, Teknoinvest, and Asset Management Company .

Capnia Secures $12 Million Series B    prweb.com